# Real Life Second-Line Nivolumab in Advanced Non-Small Cell Lung Cancer

> **NCT04858204** · — · COMPLETED · sponsor: **University Hospital, Brest** · enrollment: 259 (actual)

## Conditions studied

- NSCLC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04858204
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-14
- **Primary completion:** 2017-10-31
- **Final completion:** 2017-11-01
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04858204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04858204, "Real Life Second-Line Nivolumab in Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04858204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*